Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACNS0333: Intensive Chemotherapy and Radiation for Childhood AT/RT
NCT00653068Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Feb 2009
- Primary completion
- Sep 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of carboplatin, thiotepa in Atypical teratoid rhabdoid tumor (ATRT), sponsored by Children's Oncology Group. Started Feb 2009; status: completed.
02
Drugs
carboplatinthiotepa
03
Conditions
Atypical teratoid rhabdoid tumor (ATRT)
Beyond the preview
Go deeper on NCT00653068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653068.